# Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study

> **NCT06487026** · NA · NOT_YET_RECRUITING · sponsor: **EpiSonica** · enrollment: 25 (estimated)

## Conditions studied

- Bone Metastases

## Interventions

- **DEVICE:** ArcBlate Focused Ultrasound Ablation System

## Key facts

- **NCT ID:** NCT06487026
- **Lead sponsor:** EpiSonica
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487026, "Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06487026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
